TLR7 agonist 29
Product Specifications
Target
IFNAR|||TLR|||PD-1/PD-L1|||ADC Cytotoxin
Related Pathways
Immunology/Inflammation|||Apoptosis|||Antibody-drug Conjugate/ADC Related|||Cell Cycle/Checkpoint
Bioactivity
TLR7 agonist 29 (Compound 1) is an activator of TLR7, displaying an EC50 of 5.2 nM for human TLR7 and 48.2 nM for mouse TLR7. It can activate bone marrow-derived macrophages (BMDM) and stimulate myeloid cells within the tumor microenvironment, enhancing the expression of PD-L1, CD86, and IFN-?. Additionally, TLR7 agonist 29 can serve as a payload for synthesizing ADCs.
Molecular Formula
C20H27N7O2
Molecular Weight
397.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/315447168599064615/T205024
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1119870-01 0.02 mg (E-Coli)
Recombinant Sinapis alba Glycine-rich RNA-binding protein GRP1A
Ask
View Details 
MBS1119870-02 0.1 mg (E-Coli)
Recombinant Sinapis alba Glycine-rich RNA-binding protein GRP1A
Ask
View Details MBS1119870-03 0.02 mg (Yeast)
Recombinant Sinapis alba Glycine-rich RNA-binding protein GRP1A
Ask
View Details MBS1119870-04 0.1 mg (Yeast)
Recombinant Sinapis alba Glycine-rich RNA-binding protein GRP1A
Ask
View Details